Ameritas Investment Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.89M Buy
25,274
+7
+0% +$2.5K 0.27% 59
2025
Q4
$8.27M Buy
25,267
+1,431
+6% +$454K 0.25% 58
2025
Q3
$6.73M Buy
23,836
+180
+0.8% +$52.2K 0.21% 69
2025
Q2
$6.6M Sell
23,656
-4
-0% -$1.13K 0.21% 67
2025
Q1
$7.37M Buy
23,660
+369
+2% +$109K 0.25% 56
2024
Q4
$6.07M Buy
23,291
+736
+3% +$218K 0.2% 71
2024
Q3
$7.27M Buy
22,555
+394
+2% +$129K 0.24% 58
2024
Q2
$6.92M Sell
22,161
-78
-0.4% -$22.9K 0.24% 56
2024
Q1
$6.32M Sell
22,239
-152
-0.7% -$44.5K 0.22% 68
2023
Q4
$6.45M Buy
22,391
+493
+2% +$134K 0.24% 56
2023
Q3
$5.89M Buy
21,898
+2,991
+16% +$746K 0.24% 56
2023
Q2
$4.2M Buy
18,907
+63
+0.3% +$14.6K 0.16% 107
2023
Q1
$4.56M Sell
18,844
-8,255
-30% -$2.03M 0.18% 89
2022
Q4
$7.09M Sell
27,099
-545
-2% -$146K 0.28% 47
2022
Q3
$6.23M Buy
27,644
+3
+0% +$727 0.28% 55
2022
Q2
$6.72M Sell
27,641
-1,532
-5% -$375K 0.29% 50
2022
Q1
$7.05M Sell
29,173
-315
-1% -$72.4K 0.25% 53
2021
Q4
$6.63M Sell
29,488
-10
-0% -$2.11K 0.22% 60
2021
Q3
$6.27M Sell
29,498
-186
-0.6% -$42.8K 0.23% 61
2021
Q2
$7.24M Sell
29,684
-151
-0.5% -$37.1K 0.26% 56
2021
Q1
$7.26M Sell
29,835
-471
-2% -$112K 0.28% 49
2020
Q4
$6.97M Buy
30,306
+44
+0.1% +$10.1K 0.32% 42
2020
Q3
$7.69M Sell
30,262
-865
-3% -$214K 0.35% 40
2020
Q2
$7.34M Sell
31,127
-762
-2% -$174K 0.35% 37
2020
Q1
$6.46M Sell
31,889
-398
-1% -$86.9K 0.37% 37
2019
Q4
$7.78M Sell
32,287
-152
-0.5% -$33.5K 0.34% 36
2019
Q3
$6.28M Buy
32,439
+743
+2% +$143K 0.29% 45
2019
Q2
$5.84M Buy
31,696
+311
+1% +$55.7K 0.27% 49
2019
Q1
$5.96M Sell
31,385
-799
-2% -$153K 0.28% 45
2018
Q4
$6.26M Buy
32,184
+53
+0.2% +$10.3K 0.34% 40
2018
Q3
$6.66M Sell
32,131
-1,295
-4% -$255K 0.31% 41
2018
Q2
$6.17M Sell
33,426
-2,418
-7% -$428K 0.3% 45
2018
Q1
$6.11M Sell
35,844
-4,174
-10% -$766K 0.29% 39
2017
Q4
$6.91M Sell
40,018
-2,679
-6% -$474K 0.32% 41
2017
Q3
$7.7M Sell
42,697
-200
-0.5% -$35.4K 0.37% 36
2017
Q2
$7.39M Sell
42,897
-287
-0.7% -$46.7K 0.36% 36
2017
Q1
$7.08M Sell
43,184
-1,941
-4% -$323K 0.35% 37
2016
Q4
$6.6M Buy
45,125
+3,934
+10% +$592K 0.33% 41
2016
Q3
$6.87M Sell
41,191
-6,590
-14% -$1.11M 0.37% 34
2016
Q2
$7.27M Buy
47,781
+1,138
+2% +$177K 0.47% 34
2016
Q1
$6.99M Buy
46,643
+5,103
+12% +$758K 0.46% 32
2015
Q4
$6.74M Buy
41,540
+141
+0.3% +$22.2K 0.46% 32
2015
Q3
$5.73M Buy
41,399
+660
+2% +$104K 0.41% 36
2015
Q2
$6.25M Buy
40,739
+6,980
+21% +$1.12M 0.41% 38
2015
Q1
$5.39M Sell
33,759
-133
-0.4% -$20.9K 0.35% 44
2014
Q4
$5.4M Buy
33,892
+7,115
+27% +$1.11M 0.37% 45
2014
Q3
$3.76M Sell
26,777
-1,628
-6% -$213K 0.27% 66
2014
Q2
$3.36M Sell
28,405
-1,111
-4% -$129K 0.24% 80
2014
Q1
$3.64M Sell
29,516
-910
-3% -$110K 0.29% 69
2013
Q4
$3.47M Buy
30,426
+14,478
+91% +$1.65M 0.28% 65
2013
Q3
$1.78M Buy
+15,948
New +$1.73M 0.17% 160

Other funds holding AMGN

Ameritas Investment Partners's AMGN Position: Q1 2026 in Review

Ameritas Investment Partners increased its Amgen (AMGN) stake by 0.03% in Q1 2026, buying an estimated $2.5K and bringing the position to 25,274 shares worth $8.89M. The position accounts for 0.27% of the portfolio, ranked #59.

Ameritas Investment Partners first reported a position in AMGN in Q3 2013 and has held it in 51 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Ameritas Investment Partners held 25,274 shares of Amgen worth $8.89M as of Q1 2026.
  • Ameritas Investment Partners bought 7 Amgen shares in Q1 2026, an estimated $2.5K.
  • Amgen made up 0.27% of Ameritas Investment Partners's portfolio in Q1 2026, its #59 holding.
  • Ameritas Investment Partners first reported a position in Amgen in Q3 2013 and has held it in 51 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.